
Once our site elects to conduct a clinical trial, we carefully consider the safety of each and every potential patient during our phone screening process.
Prior to starting a clinical trial with a pharmaceutical company, our Principal Investigator (PI) carefully considers the safety of potential patients.
If the PI determines safety could pose a potential issue, our site will elect not to accept the trial.
Even if a patient qualifies for a trial, if we have any reservations regarding their safety in participation, we do not bring that patient in for the screening office visit.
Furthermore, throughout the course of the trial, we put our patients' safety first. Our team at Anderson & Collins strives to remain objective to protect the health and well being of our patients.
![]()
Just fill out our
brief form.